Skip to main content

Advertisement

Log in

Risk Factors and Clinical Aspects of Recurrent Invasive Cervical Carcinoma

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objectives

Recurrence of cervical cancer is one of the important and plausible discussions in oncology especially in patients with advanced stages. The purpose of this study was to introduce probability invasive cervical carcinoma recurrence as well as determining characteristics and the prognostic factors of this entity.

Methods

A retrospective study was designed to identify risk factors and pattern of uterine cervical carcinoma recurrence evaluating the outcome of 36 registered patients. Recurrence was defined based on clinical or para-clinical documentation over at least 6 months after complete remission following surgery or radiotherapy. Treatment consisted of a radiosurgical combination and exclusive radiotherapy.

Results

Mean age in selected patients is 54.8 ± 12.0 years. The pathological reports of primary diagnosis are squamous cell carcinoma in 94.44 % and adenocarcinoma in remaining patients. Mean duration of recurrence among patients is 2.75 ± 1.5 years after the initial treatment. Metrorrhagia is mostly revealing symptom which patients present in recurrent episode. Usually, the recurrence of cervical cancer is presented in pelvic cavity locally. Marginal involvement is documented in 50 % of cases and lymph node in 33.3 % of patients with recurrent episode being involved. Most important prognostic factors are improper treatment (16.66 % of cases) after initial diagnosis.

Conclusions

Prognostic factors such as selection of appropriate method for treatment are an important point for reducing the rate of recurrence. Moreover, warning patients about symptoms and frequent episodes of follow up is necessary for early diagnosis of recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grigsby PW. Postoperative irradiation in cervical cancer: prognostic factors and outcome. Radiat Med. 2004;22:106–10.

    PubMed  Google Scholar 

  2. Injumpa N, Suprasert P, Srisomboon J, et al. Limited value of vaginal cytology in detecting recurrent disease after radical hysterectomy for early stage cervical carcinoma. Asian Pac J Cancer Prev. 2006;7:656–8.

    PubMed  Google Scholar 

  3. Ohara K, Sugahara S, Kagei K, et al. Retrospective comparison of clinical outcome between radiotherapy alone and surgery plus postoperative radiotherapy in the treatment of stages IB–IIB cervical squamous cell carcinoma. Radiat Med. 2004;22:42–8.

    PubMed  Google Scholar 

  4. Piura B, Rabinovich A, Friger M. Recurrent cervical carcinoma after radical hysterectomy and pelvic lymph node dissection: a study of 32 cases. Eur J Gynaecol Oncol. 2008;29:31–6.

    PubMed  CAS  Google Scholar 

  5. Takehara K, Fujii T. Recurrence of uterine cervical cancer more than 5 years after initial therapy. Nippon Rinsho. 2004;62(Suppl 10):230–2.

    PubMed  Google Scholar 

  6. Fagundes H, Perez CA, Grigsby PW, et al. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1992;24:197–204.

    Article  PubMed  CAS  Google Scholar 

  7. Prempree T, Amornmarn R, Villasanta U, et al. Retreatment of very late recurrent invasive squamous cell carcinoma of the cervix with irradiation. II. Criteria for patients’ selection to achieve the success. Cancer. 1984;54:1950–5.

    Article  PubMed  CAS  Google Scholar 

  8. Barrie JR, Brunschwig A. Late second cancers of the cervix after apparently successful initial radiation therapy. Am J Roentgenol Radium Ther Nucl Med. 1970;108:109–12.

    PubMed  CAS  Google Scholar 

  9. Kasamatsu T, Onda T, Yamada T, et al. Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma. Int J Gynaecol Obstet. 2005;89:39–44.

    Article  PubMed  CAS  Google Scholar 

  10. Shingleton HM, Soong SJ, Gelder MS, et al. Jr. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol. 1989;73:1027–34.

    Article  PubMed  CAS  Google Scholar 

  11. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763–75.

    Article  PubMed  CAS  Google Scholar 

  12. Haghdel M, Ardakany MS, Zeighami B. Invasive carcinoma of the uterine cervix in Iran. Int J Gynaecol Obstet. 1999;64:265–71.

    Article  PubMed  CAS  Google Scholar 

  13. Lim KC, Howells RE, Evans AS. The role of clinical follow up in early stage cervical cancer in South Wales. Br J Obstet Gynaecol. 2004;111:1444–8.

    Article  CAS  Google Scholar 

  14. Duyn A, Van Eijkeren M, Kenter G, et al. Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand. 2002;81:759–63.

    Article  PubMed  Google Scholar 

  15. Mahe MA, Gerard JP, Dubois JB, et al. Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients. Int J Radiat Oncol Biol Phys. 1996;34:21–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sorayya Saleh-Gargari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghaemmaghami, F., Saleh-Gargari, S., Sahebdel, B. et al. Risk Factors and Clinical Aspects of Recurrent Invasive Cervical Carcinoma. J Obstet Gynecol India 62, 674–678 (2012). https://doi.org/10.1007/s13224-012-0227-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-012-0227-8

Keywords

Navigation